Clinical Trial Update: Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating everolimus in patients with lymphoma that relapsed or did not respond to prior therapy has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Mayo Clinic | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-07-30